GlobalData on MSN2d
Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial
Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral ...
Hosted on MSN1mon
Obesity treatment in a natural, food-grade microcapsule has no unpleasant side effects
"Obesity is a global epidemic with multifaceted ... inflammatory effects in a solid dosage form that can be taken as a tablet or capsule. Senior researcher, Dr. Paul Joyce says that combining ...
Morningstar16d
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...
Yahoo Finance15d
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity. Viking Therapeutics ... loss efficacy of VK2735 dosed ...